Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$37.55 - $62.64 $173,481 - $289,396
4,620 New
4,620 $289,000
Q4 2021

Feb 11, 2022

SELL
$86.26 - $119.0 $419,568 - $578,816
-4,864 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$100.17 - $126.36 $127,316 - $160,603
-1,271 Reduced 20.72%
4,864 $542,000
Q2 2021

Aug 13, 2021

BUY
$86.05 - $119.72 $238,444 - $331,744
2,771 Added 82.37%
6,135 $697,000
Q2 2020

Aug 14, 2020

SELL
$26.36 - $49.86 $106,125 - $200,736
-4,026 Reduced 54.48%
3,364 $168,000
Q4 2019

Feb 13, 2020

BUY
$32.1 - $40.4 $6,259 - $7,878
195 Added 2.71%
7,390 $249,000
Q3 2019

Nov 08, 2019

BUY
$25.38 - $34.89 $182,609 - $251,033
7,195 New
7,195 $236,000
Q4 2018

Feb 13, 2019

SELL
$12.32 - $24.38 $203,538 - $402,781
-16,521 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$18.82 - $28.96 $310,925 - $478,448
16,521 New
16,521 $396,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.3B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.